8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Mortality in COPD: Causes, Risk Factors, and Prevention

      research-article
      1 , 2
      COPD
      COPD, Mortality, Anticholinergics, Beta-agonists, Inhaled corticosteroids, Oxygen

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Chronic obstructive pulmonary disease (COPD) is a leading and increasing cause of death, the extent of which is underestimated as a consequence of underdiagnosis and underreporting on death certificates. Data from large trials, such as the Lung Health Study, Towards a Revolution in COPD Health (TORCH), Understanding Potential Long-term Impacts on Function with Tiotropium (UPLIFT), European Respiratory Society Study on Chronic Obstructive Pulmonary Disease (EUROSCOP), and Inhaled Steroids in Obstructive Lung Disease (ISOLDE), have shown that the causes of death in patients with mild COPD are predominantly cancer and cardiovascular disease, but as COPD severity increases, deaths due to non-malignant respiratory disease are increasingly common. In practice, mortality of patients with COPD can be predicted by a variety of measures including: forced expiratory volume in one second (FEV 1), the ratio of inspiratory and total lung capacities, exercise capacity, dyspnea scores, and composite indices such as the body-mass index (B), degree of airflow obstruction (O), degree of functional dyspnea (D), and exercise capacity (E) (BODE) index. Smoking cessation improves survival in COPD patients, and in select patients with advanced disease, oxygen therapy, lung volume reduction surgery, or lung transplantation may also improve survival.

          Related collections

          Author and article information

          Journal
          101211769
          33100
          COPD
          COPD
          COPD
          1541-2555
          1541-2563
          17 May 2020
          October 2010
          05 June 2020
          : 7
          : 5
          : 375-382
          Affiliations
          [1 ]Johns Hopkins University School of Medicine, Baltimore, MD, USA
          [2 ]Johns Hopkins Asthma & Allergy Center, Baltimore, MD, USA
          Author notes
          Correspondence to: Robert A. Wise, M.D., Johns Hopkins Asthma & Allergy Center, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, USA., phone: +00 1 (410) 550-0545, fax: +00 1 (410) 550–2612, rwise@ 123456jhmi.edu
          Article
          PMC7273182 PMC7273182 7273182 nihpa1595301
          10.3109/15412555.2010.510160
          7273182
          20854053
          1c5c1cd3-57e3-4519-8fa4-455ebd26fcfc
          History
          Categories
          Article

          Mortality,COPD,Oxygen,Inhaled corticosteroids,Beta-agonists,Anticholinergics

          Comments

          Comment on this article